What is the exception regarding subcutaneous nodules in Acute Rheumatic Fever (ARF) among the given statements?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Subcutaneous Nodules in Acute Rheumatic Fever: The Exception

Statement A is the EXCEPTION - it is erythema marginatum, not subcutaneous nodules, that appears as an evanescent rash appearing and disappearing before the examiner's eyes. 1

Distinguishing Between the Two Skin Manifestations

The American Heart Association clearly differentiates these two major criteria:

Erythema marginatum (the evanescent finding):

  • Unique, evanescent pink rash with pale centers and rounded or serpiginous margins 1
  • Present on trunk and proximal extremities, not facial 1
  • Heat can induce its appearance and it blanches with pressure 1

Subcutaneous nodules (NOT evanescent):

  • Firm, painless protuberances found on extensor surfaces 1
  • Located at specific joints including knees, elbows, wrists, occiput, and along spinous processes of thoracic and lumbar vertebrae 1
  • These are persistent lesions, not transient 2

Verification of the Other Statements

Statement B is TRUE:

  • Subcutaneous nodules are firm, small (typically 0.5 cm), mobile lumps beneath the skin overlying bony prominences 1

Statement C is TRUE:

  • While not explicitly stated as "2-3 weeks" in the guidelines, subcutaneous nodules are indeed a delayed manifestation 2
  • They appear in 0-10% of ARF cases, making them one of the rarer major criteria 1

Statement D is TRUE:

  • Nodules are more often observed in patients who also have carditis 1
  • One study found 90.4% of patients with subcutaneous nodules had associated carditis 2
  • However, carditis is not invariably present - approximately 9.5% of patients with nodules may not have carditis 2

Clinical Pearls

Duration and persistence:

  • With treatment, most nodules disappear within 4 weeks (69% of cases), though some persist 5-8 weeks (19%) or even 9-12 weeks (7%) 2
  • In rare cases (4.7%), nodules can persist beyond 12 weeks despite resolution of other disease activity 2

Number of nodules:

  • Average number is approximately 18 nodules (range 4-49) 2
  • Contrary to older teaching, not all patients present with large crops - 30.9% have fewer than 10 nodules 2

Diagnostic significance:

  • Subcutaneous nodules almost never occur as the sole major manifestation of ARF 1
  • They show no racial or population variability 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.